lacosamide
CHEBI:CHEBI_135939
Chemical Information
- Molecular Formula
- C13H18N2O3
- Molecular Mass
- 250.294
- Charge
- 0
- SMILES
- C(NC([C@H](NC(C)=O)COC)=O)C1=CC=CC=C1
- InChI
- InChI=1S/C13H18N2O3/c1-10(16)15-12(9-18-2)13(17)14-8-11-6-4-3-5-7-11/h3-7,12H,8-9H2,1-2H3,(H,14,17)(H,15,16)/t12-/m1/s1
- InChIKey
- VPPJLAIAVCUEMN-GFCCVEGCSA-N
Alternative Names
- erlosamide
- ertosamide
- harkoseride
- SPM-927
- vimpat
Drug Classification
-
N-acyl-amino acidView Class →
CHEBI:51569
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- DRON_00010000
- 623400
- oboInOwl#hasDbXref
- Drug_Central:4310
- core#notation
- CHEBI:135939
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- route
- INTRAVENOUS
- package_ndc
- 14445-023-02
- spl_id
- ecfbe924-b579-d999-e053-2995a90afb9d
- package_description
- 30 kg in 1 DRUM (14445-023-09)
- oboInOwl#hasOBONamespace
- chebi_ontology
- DRON_00010000
- 623400
- oboInOwl#hasDbXref
- Drug_Central:4310
- oboInOwl#id
- CHEBI:135939
- generic_name
- Lacosamide 200 mg blue film-coated tablet
- brand_name
- Lacosamide Oral Solution
- brand_name_base
- Lacosamide Oral Solution
- product_ndc
- 14445-023
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#2_STAR
- listing_expiration_date
- 20241231
- marketing_start_date
- 20220520
- product_type
- BULK INGREDIENT
- marketing_category
- BULK INGREDIENT
- dosage_form
- POWDER, FOR SOLUTION
- application_number
- ANDA205006
- rxcui
- 2637035
- manufacturer_name
- Fosun Pharma USA
- package_marketing_start_date
- 20220725
- labeler_name
- Fosun Pharma USA
- core#notation
- CHEBI:135939
- pharm_class_pe
- Decreased Central Nervous System Disorganized Electrical Activity [PE]
- pharm_class
- Decreased Central Nervous System Disorganized Electrical Activity [PE]
- dea_schedule
- CV
- upc
- 0369539027606
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- active_ingredient_strength
- 150 mg/15mL
- nui
- N0000008486
- spl_set_id
- e969b294-48d9-42a2-a093-0ac715142460
- active_ingredient_name
- LACOSAMIDE
- unii
- 563KS2PQY5
- has_treatment
- http://purl.obolibrary.org/obo/DOID_6621
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect4937
- owl#annotatedSource
- t108910
- owl#someValuesFrom
- t3982801